These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 24219068)

  • 1. An optimized protocol for overproduction of recombinant protein expression in Escherichia coli.
    Bahreini E; Aghaiypour K; Abbasalipourkabir R; Goodarzi MT; Saidijam M; Safavieh SS
    Prep Biochem Biotechnol; 2014; 44(5):510-28. PubMed ID: 24219068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular expression and single step purification of recombinant Escherichia coli L-asparaginase II.
    Khushoo A; Pal Y; Singh BN; Mukherjee KJ
    Protein Expr Purif; 2004 Nov; 38(1):29-36. PubMed ID: 15477079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of extracellular production of recombinant asparaginase in Escherichia coli in shake-flask and bioreactor.
    Khushoo A; Pal Y; Mukherjee KJ
    Appl Microbiol Biotechnol; 2005 Aug; 68(2):189-97. PubMed ID: 15660216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudomonas aeruginosa recombinant L-asparaginase: Large scale production, purification, and cytotoxicity on THP-1, MDA-MB-231, A549, Caco2 and HCT-116 cell lines.
    Saeed H; Hemida A; Abdel-Fattah M; Eldoksh A; Shalaby M; Nematalla H; El-Nikhely N; Elkewedi M
    Protein Expr Purif; 2021 May; 181():105820. PubMed ID: 33440252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cloning and optimization of induction conditions for mature PsaA (pneumococcal surface adhesin A) expression in Escherichia coli and recombinant protein stability during long-term storage.
    Larentis AL; Argondizzo AP; Esteves Gdos S; Jessouron E; Galler R; Medeiros MA
    Protein Expr Purif; 2011 Jul; 78(1):38-47. PubMed ID: 21362478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning, expression and characterization of the recombinant Yersinia pseudotuberculosis L-asparaginase.
    Pokrovskaya MV; Aleksandrova SS; Pokrovsky VS; Omeljanjuk NM; Borisova AA; Anisimova NY; Sokolov NN
    Protein Expr Purif; 2012 Mar; 82(1):150-4. PubMed ID: 22226870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of expression systems for Escherichia coli asparaginase II and two-step purification of the recombinant enzyme from periplasmic extracts.
    Harms E; Wehner A; Jennings MP; Pugh KJ; Beacham IR; Röhm KH
    Protein Expr Purif; 1991; 2(2-3):144-50. PubMed ID: 1821783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of vitreoscilla hemoglobin and culture conditions on production of bacterial L-asparaginase, an oncolytic enzyme.
    Erenler SO; Geckil H
    Appl Biochem Biotechnol; 2014 Aug; 173(8):2140-51. PubMed ID: 24970046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular expression of l-asparaginase gene from Nocardiopsis alba NIOT-VKMA08 in Escherichia coli: A prospective recombinant enzyme for leukaemia chemotherapy.
    Meena B; Anburajan L; Vinithkumar NV; Shridhar D; Raghavan RV; Dharani G; Kirubagaran R
    Gene; 2016 Sep; 590(2):220-6. PubMed ID: 27155523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning and expression of protease ClpP from Streptococcus pneumoniae in Escherichia coli: study of the influence of kanamycin and IPTG concentration on cell growth, recombinant protein production and plasmid stability.
    Einsfeldt K; Severo Júnior JB; Corrêa Argondizzo AP; Medeiros MA; Alves TL; Almeida RV; Larentis AL
    Vaccine; 2011 Sep; 29(41):7136-43. PubMed ID: 21651937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and purification of L-asparaginase from Escherichia coli and the inhibitory effects of cyclic dipeptides.
    Zhang Y; Li D; Li Y
    Nat Prod Res; 2017 Sep; 31(18):2099-2106. PubMed ID: 28105864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-step purification and kinetic properties of the recombinant L-asparaginase from Erwinia carotovora.
    Krasotkina J; Borisova AA; Gervaziev YV; Sokolov NN
    Biotechnol Appl Biochem; 2004 Apr; 39(Pt 2):215-21. PubMed ID: 15032742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced production of human mini-proinsulin in fed-batch cultures at high cell density of Escherichia coli BL21(DE3)[pET-3aT2M2].
    Shin CS; Hong MS; Bae CS; Lee J
    Biotechnol Prog; 1997; 13(3):249-57. PubMed ID: 9190075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-Asparaginase from Erwinia Chrysanthemi 3937: cloning, expression and characterization.
    Kotzia GA; Labrou NE
    J Biotechnol; 2007 Jan; 127(4):657-69. PubMed ID: 16984804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selecting and expressing protective single-chain Fv fragment to stabilize L-asparaginase against inactivation by trypsin.
    Guo L; Yan X; Qian S; Meng G
    Biotechnol Appl Biochem; 2000 Feb; 31(1):21-7. PubMed ID: 10669399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-efficiency production of bioactive recombinant human fibroblast growth factor 18 in Escherichia coli and its effects on hair follicle growth.
    Song L; Huang Z; Chen Y; Li H; Jiang C; Li X
    Appl Microbiol Biotechnol; 2014 Jan; 98(2):695-704. PubMed ID: 23624709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of a recombinant bacterial L-asparaginase in human cells.
    Dantas RC; Caetano LF; Torres ALS; Alves MS; Silva ETMF; Teixeira LPR; Teixeira DC; de Azevedo Moreira R; Fonseca MHG; Gaudêncio Neto S; Martins LT; Furtado GP; Tavares KCS
    BMC Res Notes; 2019 Dec; 12(1):794. PubMed ID: 31806048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of heterologous thermostable glycoside hydrolases and the presence of host-cell proteases in substrate limited fed-batch cultures of Escherichia coli BL21(DE3).
    Ramchuran SO; Nordberg Karlsson E; Velut S; De Maré L; Hagander P; Holst O
    Appl Microbiol Biotechnol; 2002 Dec; 60(4):408-16. PubMed ID: 12466880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of recombinant bacteriocin divercin V41 by high cell density Escherichia coli batch and fed-batch cultures.
    Yildirim S; Konrad D; Calvez S; Drider D; Prévost H; Lacroix C
    Appl Microbiol Biotechnol; 2007 Dec; 77(3):525-31. PubMed ID: 17882416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetics of native Escherichia coli asparaginase.
    Borghorst S; Pieters R; Kuehnel HJ; Boos J; Hempel G
    Pediatr Hematol Oncol; 2012 Mar; 29(2):154-65. PubMed ID: 22376019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.